Genpact (G) Stock Forecast, Price Target & Predictions
G Stock Forecast
Genpact stock forecast is as follows: an average price target of $42.80 (represents a -4.12% downside from G’s last price of $44.64) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
G Price Target
The average price target for Genpact (G) is $42.80 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $46.00 to $37.00. This represents a potential -4.12% downside from G's last price of $44.64.
G Analyst Ratings
According to 9 Wall Street analysts, Genpact's rating consensus is 'Hold'. The analyst rating breakdown for G stock is 0 'Strong Buy' (0.00%), 2 'Buy' (22.22%), 7 'Hold' (77.78%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Genpact Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | Dan Dolev | Mizuho Securities | $45.00 | $39.03 | 15.28% | 0.81% |
| Oct 09, 2024 | David Koning | Robert W. Baird | $44.00 | $38.92 | 13.05% | -1.43% |
| Aug 12, 2024 | Keith Bachman | BMO Capital | $42.00 | $36.84 | 14.01% | -5.91% |
| Jun 12, 2024 | Bryan Keane | Deutsche Bank | $37.00 | $32.67 | 13.25% | -17.11% |
| May 10, 2024 | Keith Bachman | BMO Capital | $38.00 | $34.38 | 10.53% | -14.87% |
| May 11, 2023 | Keith Bachman | Loop Capital Markets | $46.00 | $36.06 | 27.57% | 3.05% |
The latest Genpact stock forecast, released on Nov 12, 2024 by Dan Dolev from Mizuho Securities, set a price target of $45.00, which represents a 15.28% increase from the stock price at the time of the forecast ($39.03), and a 0.81% increase from G last price ($44.64).
Genpact Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 5 |
| Avg Price Target | $45.00 | $44.50 | $41.20 |
| Last Closing Price | $44.64 | $44.64 | $44.64 |
| Upside/Downside | 0.81% | -0.31% | -7.71% |
In the current month, the average price target of Genpact stock is $45.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 0.81% increase as opposed to Genpact's last price of $44.64. This month's average price target is up 1.12% compared to last quarter, and up 9.22% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 09, 2024 | Jefferies | Hold | Hold | Hold |
| Aug 12, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Aug 09, 2024 | Needham | Buy | Buy | Hold |
| Aug 09, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Jul 17, 2024 | Wedbush | Market Perform | Market Perform | Hold |
| Jul 12, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jun 12, 2024 | Deutsche Bank | Hold | Hold | Hold |
| May 10, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| May 10, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Aug 09, 2023 | BMO Capital | Market Perform | Market Perform | Hold |
Genpact's last stock rating was published by Jefferies on Sep 09, 2024. The company gave G a "Hold" rating, the same as its previous rate.
Genpact Financial Forecast
Genpact Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.15B | $1.14B | $1.11B | $1.09B | $1.10B | $1.11B | $1.09B | $1.07B | $1.07B | $1.02B | $988.13M | $946.07M | $950.57M | $935.52M | $900.09M | $923.19M | $940.74M | $888.80M |
| Avg Forecast | $1.41B | $1.39B | $1.35B | $1.30B | $1.31B | $1.28B | $1.24B | $1.21B | $1.23B | $1.19B | $1.14B | $1.11B | $1.12B | $1.16B | $1.12B | $1.10B | $1.08B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| High Forecast | $1.43B | $1.41B | $1.36B | $1.31B | $1.32B | $1.30B | $1.26B | $1.24B | $1.24B | $1.19B | $1.14B | $1.11B | $1.13B | $1.20B | $1.13B | $1.11B | $1.10B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| Low Forecast | $1.40B | $1.38B | $1.34B | $1.28B | $1.29B | $1.27B | $1.23B | $1.19B | $1.22B | $1.18B | $1.14B | $1.11B | $1.11B | $1.14B | $1.11B | $1.09B | $1.07B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 6 | 3 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.98% | 0.99% | 0.99% | 1.02% | 1.02% | 1.01% | 1.04% | 1.03% | 1.00% | 1.02% | 1.02% | 1.02% | 1.04% | 1.07% | 1.03% | 1.03% | 1.01% |
Genpact's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.11B, with a low forecast of $1.11B, and a high forecast of $1.11B. G's average Quarter revenue forecast represents a -3.17% decrease compared to the company's last Quarter revenue of $1.15B (Dec 23).
Genpact EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 6 | 3 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $162.73M | $165.69M | $185.71M | $173.16M | $131.53M | $184.38M | $142.46M | $165.73M | $153.05M | $178.99M | $191.23M | $178.87M | $153.17M | $165.37M | $134.26M | $163.76M | $161.80M | $154.46M |
| Avg Forecast | $231.41M | $228.32M | $221.18M | $212.45M | $214.21M | $210.50M | $204.06M | $197.86M | $201.66M | $194.42M | $187.52M | $184.67M | $183.89M | $189.66M | $183.33M | $167.88M | $172.10M | $166.84M | $163.72M | $152.62M | $159.05M | $154.61M | $147.18M | $142.36M | $142.53M | $137.85M | $127.92M | $134.65M | $139.08M | $134.22M |
| High Forecast | $234.15M | $231.02M | $223.79M | $214.97M | $216.75M | $212.99M | $206.47M | $202.81M | $204.05M | $194.63M | $187.52M | $221.60M | $185.53M | $196.07M | $185.50M | $201.45M | $206.52M | $166.84M | $163.72M | $183.14M | $159.05M | $154.61M | $147.18M | $170.84M | $142.53M | $137.85M | $127.92M | $161.58M | $139.08M | $134.22M |
| Low Forecast | $229.29M | $226.22M | $219.14M | $210.50M | $212.24M | $208.56M | $202.18M | $194.56M | $199.81M | $194.21M | $187.52M | $147.73M | $182.20M | $187.00M | $181.64M | $134.30M | $137.68M | $166.84M | $163.72M | $122.09M | $159.05M | $154.61M | $147.18M | $113.89M | $142.53M | $137.85M | $127.92M | $107.72M | $139.08M | $134.22M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 0.87% | 1.01% | 1.03% | 0.76% | 1.11% | 0.87% | 1.09% | 0.96% | 1.16% | 1.30% | 1.26% | 1.07% | 1.20% | 1.05% | 1.22% | 1.16% | 1.15% |
3 analysts predict G's average Quarter EBITDA for Mar 24 to be $184.67M, with a high of $221.60M and a low of $147.73M. This is 13.48% upper than Genpact's previous annual EBITDA (Dec 23) of $162.73M.
Genpact Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 6 | 3 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $291.31M | $117.59M | $116.25M | $106.10M | $89.71M | $95.84M | $71.67M | $96.18M | $73.08M | $102.39M | $102.70M | $91.27M | $74.98M | $85.44M | $62.16M | $85.70M | $82.20M | $88.12M |
| Avg Forecast | $187.18M | $180.85M | $170.91M | $153.73M | $166.19M | $162.17M | $153.53M | $141.07M | $156.24M | $145.36M | $130.57M | $101.01M | $133.20M | $134.63M | $124.23M | $91.82M | $82.18M | $127.41M | $117.01M | $83.48M | $94.39M | $101.92M | $97.59M | $72.65M | $88.78M | $89.02M | $62.22M | $70.46M | $100.66M | $94.17M |
| High Forecast | $190.06M | $183.64M | $173.54M | $156.09M | $168.74M | $164.66M | $155.89M | $146.56M | $158.06M | $145.61M | $130.57M | $121.21M | $143.99M | $138.27M | $126.15M | $110.19M | $98.62M | $127.41M | $117.01M | $100.17M | $94.39M | $101.92M | $97.59M | $87.18M | $88.78M | $89.02M | $62.22M | $84.56M | $100.66M | $94.17M |
| Low Forecast | $184.95M | $178.70M | $168.87M | $151.89M | $164.20M | $160.23M | $151.69M | $124.58M | $152.61M | $145.11M | $130.56M | $80.80M | $129.60M | $130.99M | $122.75M | $73.46M | $65.74M | $127.41M | $117.01M | $66.78M | $94.39M | $101.92M | $97.59M | $58.12M | $88.78M | $89.02M | $62.22M | $56.37M | $100.66M | $94.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.19% | 0.87% | 0.94% | 1.16% | 1.09% | 0.75% | 0.61% | 1.15% | 0.77% | 1.00% | 1.05% | 1.26% | 0.84% | 0.96% | 1.00% | 1.22% | 0.82% | 0.94% |
Genpact's average Quarter net income forecast for Mar 24 is $101.01M, with a range of $80.80M to $121.21M. G's average Quarter net income forecast represents a -65.33% decrease compared to the company's last Quarter net income of $291.31M (Dec 23).
Genpact SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 6 | 3 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $237.42M | $229.73M | $229.43M | $216.49M | $236.56M | $231.44M | $233.10M | $237.30M | $244.86M | $215.96M | $204.17M | $200.73M | $207.86M | $198.34M | $183.27M | $194.38M | $210.05M | $192.00M |
| Avg Forecast | $302.78M | $298.73M | $289.38M | $277.97M | $280.27M | $275.41M | $266.99M | $258.88M | $263.85M | $254.38M | $245.34M | $249.21M | $240.60M | $248.15M | $239.86M | $226.55M | $275.33M | $234.65M | $230.26M | $205.96M | $223.69M | $217.44M | $206.99M | $159.77M | $200.45M | $193.88M | $179.91M | $159.82M | $195.60M | $188.77M |
| High Forecast | $306.36M | $302.26M | $292.81M | $281.26M | $283.59M | $278.67M | $270.15M | $265.35M | $266.98M | $254.65M | $245.34M | $299.05M | $242.75M | $256.54M | $242.70M | $271.86M | $330.40M | $234.65M | $230.26M | $247.15M | $223.69M | $217.44M | $206.99M | $191.72M | $200.45M | $193.88M | $179.91M | $191.78M | $195.60M | $188.77M |
| Low Forecast | $300.00M | $295.98M | $286.73M | $275.42M | $277.70M | $272.88M | $264.53M | $254.56M | $261.43M | $254.10M | $245.34M | $199.36M | $238.39M | $244.67M | $237.66M | $181.24M | $220.26M | $234.65M | $230.26M | $164.76M | $223.69M | $217.44M | $206.99M | $127.81M | $200.45M | $193.88M | $179.91M | $127.86M | $195.60M | $188.77M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.93% | 0.96% | 0.96% | 0.86% | 0.99% | 1.01% | 1.15% | 1.09% | 0.99% | 0.99% | 1.26% | 1.04% | 1.02% | 1.02% | 1.22% | 1.07% | 1.02% |
Genpact's average Quarter SG&A projection for Mar 24 is $249.21M, based on 3 Wall Street analysts, with a range of $199.36M to $299.05M. The forecast indicates a 4.96% rise compared to G last annual SG&A of $237.42M (Dec 23).
Genpact EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 6 | 3 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.59 | $0.65 | $0.63 | $0.58 | $0.49 | $0.52 | $0.39 | $0.52 | $0.39 | $0.55 | $0.55 | $0.48 | $0.40 | $0.45 | $0.33 | $0.45 | $0.43 | $0.46 |
| Avg Forecast | $1.03 | $1.00 | $0.94 | $0.85 | $0.92 | $0.90 | $0.85 | $0.78 | $0.86 | $0.80 | $0.72 | $0.68 | $0.74 | $0.74 | $0.69 | $0.65 | $0.68 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| High Forecast | $1.05 | $1.02 | $0.96 | $0.86 | $0.93 | $0.91 | $0.86 | $0.81 | $0.87 | $0.81 | $0.72 | $0.68 | $0.80 | $0.76 | $0.70 | $0.66 | $0.69 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| Low Forecast | $1.02 | $0.99 | $0.93 | $0.84 | $0.91 | $0.89 | $0.84 | $0.69 | $0.84 | $0.80 | $0.72 | $0.68 | $0.72 | $0.72 | $0.68 | $0.64 | $0.67 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.16% | 0.87% | 0.92% | 0.89% | 0.72% | 0.74% | 0.60% | 0.99% | 0.75% | 0.98% | 1.02% | 0.99% | 0.82% | 0.91% | 0.96% | 1.00% | 0.77% | 0.88% |
According to 3 Wall Street analysts, Genpact's projected average Quarter EPS for Mar 24 is $0.68, with a low estimate of $0.68 and a high estimate of $0.68. This represents a -57.16% decrease compared to G previous annual EPS of $1.59 (Dec 23).
Genpact Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TTEC | TTEC | $4.48 | $35.67 | 696.21% | Hold |
| TWKS | Thoughtworks | $4.47 | $13.63 | 204.92% | Hold |
| CLVT | Clarivate | $5.09 | $14.33 | 181.53% | Buy |
| WNS | WNS | $50.86 | $72.86 | 43.26% | Buy |
| CDW | CDW | $175.99 | $232.80 | 32.28% | Buy |
| ASGN | ASGN | $85.08 | $99.00 | 16.36% | Hold |
| JKHY | Jack Henry & Associates | $171.12 | $191.80 | 12.09% | Buy |
| CACI | CACI | $454.90 | $492.78 | 8.33% | Buy |
| PRFT | Perficient | $75.96 | $81.00 | 6.64% | Hold |
| SAIC | Science Applications | $123.05 | $124.30 | 1.02% | Buy |
| G | Genpact | $44.64 | $42.80 | -4.12% | Hold |
| BR | Broadridge Financial Solutions | $225.39 | $184.33 | -18.22% | Buy |
| EXLS | ExlService | $44.38 | $32.64 | -26.45% | Buy |